0.3743
+0.0333
+(9.77%)
At close: April 15 at 4:00:01 PM EDT
0.3643
-0.01
(-2.67%)
Pre-Market: 8:00:02 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.34M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LAWLOR AUGUSTINE Chief Operating Officer | -- | Direct | -- | Mar 28, 2025 |
| MIRABELLI CHRISTOPHER K Chairman of the Board | -- | Direct | -- | Mar 28, 2025 |
| ONSI DOUGLAS E Chief Executive Officer | -- | Direct | -- | Mar 28, 2025 |
| SIRARD CYNTHIA M.D. Officer | -- | Direct | -- | Mar 28, 2025 |
| O'MAHONY JOHN MARK Officer | -- | Direct | -- | Mar 28, 2025 |
| GRANFIELD CHRISTINE Officer | -- | Direct | -- | Mar 28, 2025 |
| BAUM JASON Officer | -- | Direct | -- | Mar 28, 2025 |
| LAWLOR AUGUSTINE Chief Operating Officer | Conversion of Exercise of derivative security at price 2.82 per share. | Indirect | 6,024 | Nov 13, 2024 |
| CAVANAUGH JAMES H Director | Conversion of Exercise of derivative security at price 2.82 per share. | Direct | 601 | Nov 13, 2024 |
| MIRABELLI CHRISTOPHER K Chairman of the Board | Conversion of Exercise of derivative security at price 2.82 per share. | Indirect | 6,024 | Nov 13, 2024 |
| ONSI DOUGLAS E Chief Executive Officer | Conversion of Exercise of derivative security at price 2.82 per share. | Indirect | 6,024 | Nov 13, 2024 |
| LAWLOR AUGUSTINE Chief Operating Officer | -- | Direct | -- | Jan 26, 2024 |
| MIRABELLI CHRISTOPHER K Chairman of the Board | -- | Direct | -- | Jan 26, 2024 |
| ONSI DOUGLAS E Chief Executive Officer | -- | Direct | -- | Jan 26, 2024 |
| SIRARD CYNTHIA M.D. Officer | -- | Direct | -- | Jan 26, 2024 |
| O'MAHONY JOHN MARK Officer | -- | Direct | -- | Jan 26, 2024 |
| ONSI DOUGLAS E Chief Executive Officer | -- | Direct | -- | Mar 17, 2023 |
| BEIGENE LTD Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.85 per share. | Direct | 7,249,830 | Sep 24, 2021 |
| PERCEPTIVE ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.00 per share. | Indirect | 3,500,000 | Jun 22, 2020 |
| LAWLOR AUGUSTINE Chief Operating Officer | Purchase at price 1.75 per share. | Indirect | 999,999 | Feb 5, 2019 |
| MIRABELLI CHRISTOPHER K Chief Executive Officer | Purchase at price 1.75 per share. | Indirect | 999,999 | Feb 5, 2019 |
| HEALTHCARE VENTURES VIII, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.75 per share. | Indirect | 999,999 | Feb 5, 2019 |
| ONSI DOUGLAS E General Counsel | Purchase at price 1.75 per share. | Indirect | 999,999 | Feb 5, 2019 |
| HEALTHCARE VENTURES IX, L.P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.39 per share. | Indirect | 794,285 | Feb 5, 2019 |
| LAWLOR AUGUSTINE Chief Operating Officer | Purchase at price 6.08 per share. | Indirect | 6,436,524 | Nov 14, 2017 |
| MIRABELLI CHRISTOPHER K Chief Executive Officer | Purchase at price 6.08 per share. | Indirect | 6,436,524 | Nov 14, 2017 |
| HEALTHCARE VENTURES VIII, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 6.08 per share. | Indirect | 6,436,524 | Nov 14, 2017 |
| ONSI DOUGLAS E General Counsel | Purchase at price 6.08 per share. | Indirect | 6,436,524 | Nov 14, 2017 |
| HEALTHCARE VENTURES IX, L.P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 6.08 per share. | Indirect | 6,436,524 | Nov 14, 2017 |
Related Tickers
CRVS Corvus Pharmaceuticals, Inc.
3.2400
+6.93%
AFMD Affimed N.V.
0.7210
-8.84%
ELEV Elevation Oncology, Inc.
0.3135
+6.71%
MREO Mereo BioPharma Group plc
2.0000
+5.26%
VINC Vincerx Pharma, Inc.
0.2750
+7.34%
BDTX Black Diamond Therapeutics, Inc.
1.4200
+1.43%
SPRB Spruce Biosciences, Inc.
0.1320
-58.02%
PSTV Plus Therapeutics, Inc.
0.6510
+1.80%
XFOR X4 Pharmaceuticals, Inc.
0.2080
+1.56%
SGMO Sangamo Therapeutics, Inc.
0.7382
-1.64%